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Fig. 2. Temporal profile of NITEGE fragment in Guinea Pig synovial fluid lavage.
Data represents mean ± Standard error of the mean.
a function of age and disease progression (p<0.045 at 3 and 6
months), with the medial cartilage levels being greater than the
corresponding lateral compartment (Figure 1).
A similar time-dependant increase in aggrecanase-generated
fragments was observed in synovial fluid lavages from selected
groups of the same animals (Figure 2). These increased levels
of neo-epitope correlate with degenerative changes occurring
within the cartilage extracellular matrix.
Conclusions: The Dunkin Hartley guinea pig displays a spon-
taneous onset of progressive degenerative changes that closely
resemble the development of osteoarthritis in humans. Earliest
histological signs are observed in the medial tibial compart-
ment at 3 months of age with moderate and severe degenerative
changes at one year old (1). In this study aggrecanase-generated
neo-epitope was present in medial tibial cartilage at 3 and 4
months of age and appeared to precede cartilage destruction,
levels were maximum at 6 months at typical on-set of disease
and these levels were maintained as the disease progressed.
This is similar to human arthritis where aggrecan neo-epitope
fragments have been shown to increase with disease in hu-
man arthritic synovial fluids (2). This study thus reinforces the
relevance of the guinea pig model for testing chondroprotective
drugs and their potential role relative to disease state and activity
in disease modification in OA.
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THINNING OF THE SUBCHONDRAL PLATE AND
TRABECULAR BONE CHANGES IN THE CANINE
GROOVE MODEL AND ACLT MODEL OF
OSTEOARTHRITIS
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Purpose: We evaluated the changes in peri-articular bone in two
canine models of osteoarthritis: the groove model, in which the
articular cartilage of the femoral condyles is surgically damaged,
and the ACLT model.
Methods: Tibial plateaus were evaluated at 10 and 20 weeks
post-surgery for the groove and ACLT model and also at 3
weeks for the groove model. Cartilage integrity was analysed
and architecture of subchondral plate and trabecular bone of
epiphyses was quantified using micro-CT.
Results: Cartilage histology/biochemistry demonstrated the
characteristic features of osteoarthritis for the groove model at 10
and 20 weeks (no changes at 3 weeks) and the ACLT model. The
groove model presented osteophytes only at 20 weeks, whereas
the ACLT showed osteophytes already at 10 weeks.
Trabecular bone volume fraction (BV/TV) and trabecular thick-
ness in the groove model showed a slight increase at 3 and
10 weeks (+6%), to a slight decrease at 20 weeks (-4%). This
contrasts the ACLT model in which BV/TV was clearly reduced
at 10 and 20 weeks (15-20%). In contrast, the changes in the
subchondral plate were very consistent in both models at all
time points. For both models the subchondral plate thickness
drastically reduced (25-40%) in all animals and plate porosity
increased (25-85%) in all animals, already clearly detectable at
3 weeks in the groove model.
Conclusions: These findings indicate differential regulation of
subchondral trabecular bone in the groove and ACLT model.
The changes in the subchondral plate were similar in both
models. The very early changes in plate thickness and porosity
in the groove model (after 3 weeks), in the absence of cartilage
changes, demonstrates that bone changes precede cartilage
changes and may implicate an etiological role for subchondral
bone in the onset of osteoarthritis.
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Purpose: Intra-articular injection of hyaluronan preparations is
commonly utilized in the treatment of osteoarthritis (OA), how-
ever, it often required 3-5 administrations to achieve efficacy.
Gel-200 is a newly developed cross-linked hyaluronate hydrogel
as a novel therapeutic agent for the knee OA. The objective of
this study was to examine the efficacy of Gel-200 in the rabbit
ACL transection model. The ACL transection model used in this
study has been accepted as an arthritis model, which produces
cartilage degradation similar to OA in humans.
Methods: Experimental OA was induced in 48 male rabbits by
transecting the unilateral ACL. Four weeks after the ACL transec-
tion, Gel-200 was administered once or twice (at an interval of 2
weeks) into the joint cavity of the left hind knee at a dose of 0.05
mL/kg/joint. Its efficacy was compared to that of repeated ad-
ministration of PBS or SUPARTZ® once a week for 5 weeks. All
animals were sacrificed 9 weeks after ACL transection. The left
knee joints were then removed and evaluated by morphological
assessment of cartilage degeneration, volume of synovial fluid
and protein content, number of infiltrated cells and glycosamino-
glycans content in synovial fluid as indicators of synovitis, and
histopathological examination of the cartilage and synovium.
Results: In the morphological assessment, cartilage degenera-
tion was less in the Gel-200 groups compared to the SUPARTZ®.
In fact, in both the one- and two-injections Gel-200 groups the
degeneration of the articular cartilage was significantly less com-
pared with control treated with 5-weekly injections of PBS. In
contrast, SUPARTZ® administration decreased the cartilage de-
generation compared with control, but the efficacy was not sig-
nificant. The severity comparison among the test substances
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were in the following order: PBS > SUPARTZ® > 1 injection
of Gel-200 ≥ 2 injections of Gel-200. Efficacy of Gel-200 for
suppression of cartilage degeneration was also demonstrated
by a reduction of the increase in chondroitin 6-sulfate (6S) in
the synovial fluid. In addition, Gel-200 appeared to improve the
symptoms of synovitis, as judged from the reduction in increase
of synovial fluid, protein and chondroitin 4-sulfate (4S) contents.
Overall, since cartilage degeneration is milder when synovitis
is not severe, these changes induced by Gel-200 may interact
beneficially to relieve the progression of pathological changes.
Histopathological findings of articular cartilage supported the
morphological assessment. In the histopathological examination
of synovium, cuboidal/stratified synovial epithelium, subepithe-
lial cellular infiltration, subepithelial fibrosis/edema, subepithelial
hemorrhage and subepithelial calcium deposition were observed
in all the experimental groups. These changes were less severe
in Gel-200 groups compared to those in the control group.
Conclusions: These data show that in a rabbit ACL transection
model of OA, a single intra-articular injection of Gel-200 was
superior to five injections of SUPARTZ® in slowing cartilage
degeneration. It is considered that this superiority of Gel-200 is
attributed to its highly cross-linked structure.
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THE IN VIVO ACTIVATION OF PPARγ BY THE LIGAND
PIOGLITAZONE REDUCES THE DEVELOPMENT OF
CARTILAGE LESIONS AND SYNTHESIS OF CATABOLIC
FACTORS IN AN OSTEOARTHRITIS DOG MODEL
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Purpose: The peroxisome proliferator-activated receptor
(PPAR)γ is a known modulator of a number of inflammatory
pathways. Emerging evidence indicates that PPARγ may have
protective effects on structural changes in osteoarthritis (OA). In
this study we evaluated the in vivo therapeutic effect of a PPARγ
agonist, pioglitazone, on the development of structural lesions in
a dog anterior cruciate ligament (ACL) model of OA and explored
the effect of the drug on the major synthetic pathways involved
in the disease process.
Methods: OA was surgically induced in 24 dogs. The OA dogs
were randomly divided into 3 groups (n=8 per group) and treated
orally with either placebo, 15 mg/kg/day of pioglitazone, or 30
mg/kg/day of pioglitazone. The treatment began the day after
surgery and continued for a period of 8 weeks. The severity of
cartilage lesions was scored macroscopically. Cartilage speci-
mens from femoral condyles and tibial plateaus were processed
for histologic evaluation. Both cartilage and synovial membrane
were processed for quantitative RT-PCR and immunohistochem-
istry. Specific probes and antibodies were used to study iNOS,
MMP-1 and ADAMTS-5.
Results: Pioglitazone treatment reduced the development of
cartilage lesions in a dose-dependent manner. There was a
reduction in the lesion scores, and statistical significance was
reached for the medial condyle; p<0.04 and 0.03 respectively for
15 and 30 mg/kg/day of pioglitazone. This decrease correlated
with the cartilage histologic scores. Pioglitazone also significantly
reduced the production of OA key mediators, iNOS, MMP-1 and
ADAMTS-5 in cartilage.
Conclusions: This study demonstrated the efficacy of pioglita-
zone, a PPARγ agonist, at reducing articular lesions in a dog
model of OA. These results provide a new possibility for thera-
peutic intervention in OA, in which in vivo activation of PPARγ
inhibits major cartilage catabolic factors responsible for articular
tissue degradation.
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Purpose: To investigate and compare the characteristics of the
reconstructed articular surface microscopically and histologically
after a time period of 6 weeks following the treatment of a focal
defect of the right femoral head with subchondral drilling and
autologous osteochondral transplantation in rabbits
Methods: A 2,5 mm diameter and 3 mm depth iatrogenic os-
teochondral defect in the anterolateral weight bearing area of
the right femoral head was created in 12 rabbits. In a group of
6 rabbits the lesion was treated with autologous osteochondral
transplantation. The donor site for the transplant was the lat-
eral condyle of the ipsilateral knee joint. The other group of 6
rabbits was treated with subchondral drilling. Both groups were
sacrificed after a time period of 6 weeks and specimens were
evaluated histologically under the classification system of the
ICRS. For statistical analysis we used the Mann - Wittney test
Results: According to the ICRS score statistical significance was
found for all variables between the 2 groups (subchondral drilling
6 weeks vs autologous osteochondral transplantation 6 weeks):
articular surface (p=0,049), matrix (p=0,003), cell distribution (p<
0,0005), subchondral bone (p=0,010), cartilage mineralization
(p=0,0) except cell population viability.
Conclusions: In cases of focal osteochondral defect of the
femoral head in rabbits, reconstruction of the articular surface
through autologous osteochondral graft transplantation gives su-
perior macroscopical and histological results in comparison to
subchondral drilling
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Purpose: Interleukin-1 (IL-1) is thought to play a role in both
the joint destruction seen in osteoarthritis (OA) and the pain that
develops with the disease. The monoiodoacetate (MIA) model of
osteoarthritis in the rat has been used as a model of OA pain
and additionally, displays gross pathology and histologic changes
that resemble some components of OA pathology. This study
therefore uses the MIA model to examine the effect of the IL-1
receptor antagonist (IL-1RA) Anakinra on cartilage degradation
and joint pain.
Methods: 20 male Lewis rats of 7 weeks of age were randomized
into 2 experimental groups of n=10. The rats were then implanted
with Alzet osmotic pumps (model 2ML) containing either vehicle
(PBS) or IL-1RA at a dose of 90mg/kg per day. Three days
after osmotic pump implantation the right knees of each rat
were injected with 0.3mg of MIA in 50ul of saline and the
left knees with 50ul of saline. 6 rats from each group were
then measured for pain on days 1, 2, 3,8,10 and 14 post MIA
injection by incapacitance testing. This measures the difference
in paw weight bearing between the MIA and saline injected
